Journal
CELLS
Volume 12, Issue 20, Pages -Publisher
MDPI
DOI: 10.3390/cells12202489
Keywords
ACTD; cell cultures; systemic sclerosis; lupus erythematosus; rheumatoid arthritis; primary cell cultures; 2D cultures; 3D cultures; PBMC; fibroblasts
Categories
Ask authors/readers for more resources
Cell cultures play a significant role in the research and treatment of autoimmune connective tissue diseases (ACTDs). Culturing different cell types involved in ACTDs helps broaden knowledge of these diseases, potentially leading to finding cures. By analyzing gene expression patterns, surface proteins, and cytokine profiles in cell cultures, potential biomarkers can be identified for diagnosing, monitoring disease activity, and predicting treatment response. Moreover, cell culturing allows evaluation of the effects of therapies on patient-specific cell populations, aiding in personalized medicine.
Cell cultures are an important part of the research and treatment of autoimmune connective tissue diseases. By culturing the various cell types involved in ACTDs, researchers are able to broaden the knowledge about these diseases that, in the near future, may lead to finding cures. Fibroblast cultures and chondrocyte cultures allow scientists to study the behavior, physiology and intracellular interactions of these cells. This helps in understanding the underlying mechanisms of ACTDs, including inflammation, immune dysregulation and tissue damage. Through the analysis of gene expression patterns, surface proteins and cytokine profiles in peripheral blood mononuclear cell cultures and endothelial cell cultures researchers can identify potential biomarkers that can help in diagnosing, monitoring disease activity and predicting patient's response to treatment. Moreover, cell culturing of mesenchymal stem cells and skin modelling in ACTD research and treatment help to evaluate the effects of potential drugs or therapeutics on specific cell types relevant to the disease. Culturing cells in 3D allows us to assess safety, efficacy and the mechanisms of action, thereby aiding in the screening of potential drug candidates and the development of novel therapies. Nowadays, personalized medicine is increasingly mentioned as a future way of dealing with complex diseases such as ACTD. By culturing cells from individual patients and studying patient-specific cells, researchers can gain insights into the unique characteristics of the patient's disease, identify personalized treatment targets, and develop tailored therapeutic strategies for better outcomes. Cell culturing can help in the evaluation of the effects of these therapies on patient-specific cell populations, as well as in predicting overall treatment response. By analyzing changes in response or behavior of patient-derived cells to a treatment, researchers can assess the response effectiveness to specific therapies, thus enabling more informed treatment decisions. This literature review was created as a form of guidance for researchers and clinicians, and it was written with the use of the NCBI database.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available